Clinical Trials List
2021-11-01 - 2024-12-31
Others
Recruiting1
ICD-10G44.051
Short lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT), intractable
ICD-10G44.059
Short lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT), not intractable
ICD-10G44.091
Other trigeminal autonomic cephalgias (TAC), intractable
ICD-10G44.099
Other trigeminal autonomic cephalgias (TAC), not intractable
ICD-10G44.1
Vascular headache, not elsewhere classified
ICD-10G44.301
Post-traumatic headache, unspecified, intractable
ICD-10G44.309
Post-traumatic headache, unspecified, not intractable
ICD-10G44.311
Acute post-traumatic headache, intractable
ICD-10G44.319
Acute post-traumatic headache, not intractable
ICD-10G44.321
Chronic post-traumatic headache, intractable
ICD-10G44.329
Chronic post-traumatic headache, not intractable
ICD-10G44.40
Drug-induced headache, not elsewhere classified, not intractable
ICD-10G44.41
Drug-induced headache, not elsewhere classified, intractable
ICD-10G44.52
New daily persistent headache (NDPH)
ICD-10G44.53
Primary thunderclap headache
ICD-10G44.59
Other complicated headache syndrome
ICD-10G44.81
Hypnic headache
ICD-10G44.82
Headache associated with sexual activity
ICD-10G44.83
Primary cough headache
ICD-10G44.84
Primary exertional headache
ICD-10G44.85
Primary stabbing headache
ICD-10G44.89
Other headache syndrome
ICD-10R51
Headache
ICD-9784.0
Headache
-
Trial Applicant
SINEW PHARMA INC.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 王永志 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
48 participants
-
Global
0 participants